[go: up one dir, main page]

GT199700061A - Procedimiento para la obtencion de "compuestos antipicornavirales y metodos para su uso y preparacion". - Google Patents

Procedimiento para la obtencion de "compuestos antipicornavirales y metodos para su uso y preparacion".

Info

Publication number
GT199700061A
GT199700061A GT199700061A GT199700061A GT199700061A GT 199700061 A GT199700061 A GT 199700061A GT 199700061 A GT199700061 A GT 199700061A GT 199700061 A GT199700061 A GT 199700061A GT 199700061 A GT199700061 A GT 199700061A
Authority
GT
Guatemala
Prior art keywords
compounds
picornaviral
novelty
proteases
protease inhibitors
Prior art date
Application number
GT199700061A
Other languages
English (en)
Inventor
Steven Weber
Peter S Dragovich
Thomas J Prins
Siegfried Reich
Thomas L Little Jr
Ethel S Littlefield
Joseph T Marakovits
Ted M Bleckman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27360847&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT199700061(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/850,398 external-priority patent/US5856530A/en
Application filed filed Critical
Publication of GT199700061A publication Critical patent/GT199700061A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06052—Val-amino acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LOS INHIBIDORES DE PROTEASAS DE 3C PICORNAVIRALES, OBTENIBLES POR SINTESIS QUIMICA, INHIBEN O BLOQUEAN LA ACTIVIDAD BIOLOGICA DE LAS PROTEASAS DE 3C PICORNAVIRALES. ESTOS COMPUESTOS, ASI COMO LAS COMPOSICIONES FARMACEUTICAS QUE CONTIENEN ESTOS COMPUESTOS, SON APTOS PARA TRATAR A PACIENTES O HUESPEDES INFECTADOS CON UN PICORNAVIRUS O MAS. SE PUEDE UTILIZAR VARIOS METODOS E INTERMEDIOS NOVEDOSOS PARA PREPARAR LOS INHIBIDORES DE PROTEASAS DE 3C PICORNAVIRALES NOVEDOSOS DE ESTA INVENCION. LOS INVENTORES DEMUESTRAN QUE LOS COMPUESTOS DE ESTA INVENCION SE ENLAZAN CON LAS PROTEASAS DE 3C RINOVIRUS Y PREFERENTEMENTE TIENEN ACTIVIDAD DE CULTIVO CELULAR ANTIVIRAL. LA INVENCION APUNTA A UN PROTOTIPO DE ESTRUCTURA QUIMICA (V. FORMULA I), DONDE: R1...{H,F, R, OH, SH, OR, SR; R2 & R5...{UN GRUPO DE COMPUESTOS LISTADOS; Z...{H,F, R, CICLOR, HETEROCICLO, AR, C(O)R, CON(R), NO2, SO(R); DEBERA REVISARSE EL EXPEDIENTE ORIGINAL PARA EJEMPLIFICAR COMPUESTOS ESPECIFICOS.
GT199700061A 1996-05-14 1997-05-13 Procedimiento para la obtencion de "compuestos antipicornavirales y metodos para su uso y preparacion". GT199700061A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64568796A 1996-05-14 1996-05-14
US1766696P 1996-05-14 1996-05-14
US08/850,398 US5856530A (en) 1996-05-14 1997-05-02 Antipicornaviral compounds and methods for their use and preparation

Publications (1)

Publication Number Publication Date
GT199700061A true GT199700061A (es) 1998-11-04

Family

ID=27360847

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199700061A GT199700061A (es) 1996-05-14 1997-05-13 Procedimiento para la obtencion de "compuestos antipicornavirales y metodos para su uso y preparacion".

Country Status (12)

Country Link
EP (1) EP0910572B1 (es)
JP (1) JP2000506903A (es)
AR (1) AR007128A1 (es)
AT (1) ATE294187T1 (es)
AU (1) AU722704B2 (es)
CA (1) CA2254343A1 (es)
CO (1) CO4950551A1 (es)
DE (1) DE69733137T2 (es)
ES (1) ES2242225T3 (es)
GT (1) GT199700061A (es)
PA (1) PA8429901A1 (es)
WO (1) WO1997043305A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214799B1 (en) 1996-05-14 2001-04-10 Agouron Pharmaceuticals, Inc. Antipicornaviral compounds and methods for their use and preparation
US5962487A (en) * 1997-12-16 1999-10-05 Agouron Pharmaceuticals, Inc. Antipicornaviral compounds and methods for their use and preparation
KR20010043004A (ko) 1998-04-30 2001-05-25 개리 이. 프라이드만 피코르나 바이러스 억제 화합물, 그의 제조 방법 및 용도
EP1329457B1 (en) * 1998-04-30 2005-11-02 Agouron Pharmaceuticals, Inc. Antipicornaviral compounds, their preparation and use
KR20020025964A (ko) 1999-08-04 2002-04-04 개리 이. 프라이드만 피코르나바이러스 억제 화합물 및 조성물, 그의 약학적용도, 및 그의 합성용 물질
US6774243B2 (en) 1999-08-24 2004-08-10 Agouron Pharmaceuticals, Inc. Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates
PE20010517A1 (es) * 1999-08-24 2001-05-16 Agouron Pharma Las rutas sinteticas eficientes para la preparacion de los inhibidores de la proteasa del rinovirus y los intermedios claves
US6355807B1 (en) 1999-08-24 2002-03-12 Agouron Pharmaceuticals, Inc. Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates
PE20020157A1 (es) * 1999-12-03 2002-02-22 Agouron Pharma Compuestos derivados de piridona como inhibidores de proteasas de picornaviral 3c, composiciones, sus usos farmaceuticos y materiales para su sintesis
PA8515201A1 (es) 2000-04-14 2002-10-24 Agouron Pharma Compuestos y composiciones antipicornavirales; sus usos farmaceuticos y los materiales para su sintesis
CA2408913A1 (en) 2000-05-16 2001-11-22 Takeda Chemical Industries, Ltd. Melanin-concentrating hormone antagonist
HUP0301331A3 (en) * 2000-06-14 2004-03-01 Agouron Pharmaceuticals Inc La Antipicornaviral compounds process for their preparation and compositions containing them, their pharmaceutical uses, and intermediates for their synthesis
US7192972B2 (en) 2002-03-22 2007-03-20 Eisai Co., Ltd. Hemiasterlin derivatives and uses thereof
US7064211B2 (en) 2002-03-22 2006-06-20 Eisai Co., Ltd. Hemiasterlin derivatives and uses thereof
US7462594B2 (en) 2003-12-31 2008-12-09 Taigen Biotechnology Co., Ltd. Peptide-like compounds that inhibit coronaviral 3CL and flaviviridae viral proteases
CA2550515A1 (en) * 2003-12-31 2005-07-21 Taigen Biotechnology Protease inhibitors
CA2724785C (en) 2008-05-21 2018-08-07 New World Laboratories Inc. Selective caspase inhibitors and uses thereof
US20100152452A1 (en) * 2008-12-15 2010-06-17 Taigen Biotechnology Co., Ltd. Stereoselective synthesis of piperidine derivatives
US9045524B2 (en) 2009-05-21 2015-06-02 Novagenesis Foundation Selective caspase inhibitors and uses thereof
ES2665301T3 (es) 2011-04-15 2018-04-25 Genesis Technologies Limited Inhibidores selectivos de cisteína proreasa y usos de los mismos
US9474759B2 (en) 2011-09-27 2016-10-25 Kansas State University Research Foundation Broad-spectrum antivirals against 3C or 3C-like proteases of picornavirus-like supercluster: picornaviruses, caliciviruses and coronaviruses
EP2844249A4 (en) 2012-05-02 2016-03-09 Univ Kansas State MACROCYCLIC AND PEPTIDOMIMETIC COMPOUNDS AS VIRUZIDES AGAINST 3C OR 3C LIKE PROTEASES OF PICORNIVERS, CALICIVIRES AND CORONA VIRUSES
US20230151034A1 (en) * 2020-03-17 2023-05-18 Cocrystal Pharma, Inc. Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication
WO2022156692A1 (zh) * 2021-01-22 2022-07-28 中国人民解放军军事科学院军事医学研究院 一种环肽类病毒蛋白酶抑制剂，其制备方法，及其在抗病毒药物中的应用

Also Published As

Publication number Publication date
AU3005997A (en) 1997-12-05
DE69733137D1 (de) 2005-06-02
CO4950551A1 (es) 2000-09-01
CA2254343A1 (en) 1997-11-20
EP0910572A1 (en) 1999-04-28
DE69733137T2 (de) 2006-03-02
AU722704B2 (en) 2000-08-10
ATE294187T1 (de) 2005-05-15
PA8429901A1 (es) 2000-09-29
AR007128A1 (es) 1999-10-13
WO1997043305A1 (en) 1997-11-20
ES2242225T3 (es) 2005-11-01
EP0910572B1 (en) 2005-04-27
JP2000506903A (ja) 2000-06-06

Similar Documents

Publication Publication Date Title
GT199700061A (es) Procedimiento para la obtencion de "compuestos antipicornavirales y metodos para su uso y preparacion".
ES2181725T3 (es) Inhibidores de hiv proteasa.
ES2190803T3 (es) Iminas ciclicas como pesticidas.
BR0210839A (pt) Sistema de recombinação, método para remover uma sequência de dna do dna cromossÈmico de uma célula ou organismo eucarióticos, organismo, cultura de célula, órgão, tecido, parte ou material de propagação transgênico, e, uso de um organismo ou de uma cultura de célula, órgão, tecido, parte ou material de propagação transgênico
ES2130574T3 (es) Agentes de restriccion de las citoquinas.
DE60207198D1 (de) Transplantate für die wiederherstellung von osteochondralen schäden
ES2040208T3 (es) Pirazolinas insecticidas.
AR023071A1 (es) Compuestos de piridincetona, compuestos intermediarios, composicion herbicida e inhibidora del crecimiento de plantas, metodo para controlar la vegetacion indeseada, metodo para inhibir el crecimiento de las plantas, y uso de la composicion para controlar el crecimiento indeseado de plantas.
EA200801206A1 (ru) Композиция, стимулирующая рост растений, содержащая соединение семейства кофеина
GT199700033A (es) Derivados de 6-fenilpiridil-2-amina.
AR011116A1 (es) Compuesto derivado de n-hidroxi-beta-sulfonil propionamida y composicion farmaceutica que lo contiene
GT200100007A (es) Antagonistas del factor liberador de corticotropina.
PA8547601A1 (es) Inhibidores de la proteasa del vih, composiciones que los contienen, sus usos farmaceuticos y materiales para su sintesis
PA8507801A1 (es) Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis
AR036827A1 (es) Queratinocitos utilizables como sustancia biologicamente activa en el tratamiento de heridas
ECSP055609A (es) "Uso de inhibidores de la IkB-quinasa para el tratamiento del dolor"
BR9813651A (pt) Compostos antipicornavirais e métodos para o seu uso e preparação
BG66080B1 (bg) Заместени тиоацетамиди
GT199800083A (es) Agonistas de prostaglandinas.
ES2193144T3 (es) Compuestos de dna que comprenden secuencias que codifican manuronano c-5-epimerasa.
DK0483201T3 (da) Y-zeolit-baseret katalytisk samamensætning, som er anvendelig ved behandling af oxygenholdige udløbsstrømme indeholdende nitrogenoxider, fremstilling deraf og fremgangsmåde til anvendelse deraf
SV2001000379A (es) Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y materiales para su sintesis.
ATE369348T1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
AR015685A1 (es) Compuesto de heteroarilcarboxamida o una sal fisiologicamente aceptable del mismo y su uso para la preparacion de una composicion farmaceutica
AR012124A1 (es) Un procedimiento para la preparacion de derivados de tiazolidinadiona, derivados de tiazolidinadiona, su uso y preparados farmaceuticos que contienen a dichos derivados.